Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Telos Rx vs Ondra Health

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.

Grade B · #21

Telos Rx

Carries one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

Visit Telos Rx
vs
WinnerGrade B+ · #3

Ondra Health

A rare combination: near-cheapest semaglutide, nationwide reach, brand-name access and a LegitScript-verified operation.

Visit Ondra Health

The verdict

Winner: Ondra Health

Ondra Health takes it with a higher Verdict Score — 89/100 to 85/100 (grade B+ vs B). Value shoppers who refuse to trade price for legitimacy — the strongest all-around bargain on the board. Telos Rx still earns its place — patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

83Real-world results88
82Price honesty91
87Prescriber access91
92Formulary choice88
83Cancellation fairness87
84Member support87

Price, coverage & features

MetricTelos RxOndra Health
Verdict Score85/10089/100
GradeBB+
Semaglutide$49/mo (microdosed, annual)$93/mo
Tirzepatide$99/mo (annual)$166/mo
CoverageNot publicly listedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesNo

Telos Rx

What we like

  • Unusually deep published menu — compounded semaglutide and tirzepatide alongside PT-141, intranasal NAD+, and recovery peptides (sermorelin, ipamorelin, CJC-1295, BPC-157)
  • Needle-free and oral routes, including oral and microdosed tirzepatide, for the needle-averse
  • LegitScript-certified and HIPAA-compliant, with US-based providers and pharmacies, plus HSA/FSA and free 48-hour shipping
  • Low published GLP-1 entry — from $49/mo microdosed and $99/mo tirzepatide on annual plans

The caveats

  • Everything is compounded, not FDA-approved — including the peptides, several of which are research-grade with limited human evidence
  • Pricing turns opaque outside the headline GLP-1 tiers, and the cheapest rates require a long annual lock-in (short plans run $145/$199/$399 in the first month)
  • No named clinicians or leadership, and only a thin body of public reviews
  • States served are not published, so confirm your state is covered before you sign up

Ondra Health

What we like

  • Among the lowest disclosed compounded-semaglutide prices anywhere
  • LegitScript-certified with brand-name access on top of compounded
  • Available in all 50 states

The caveats

  • Tirzepatide is priced higher than its standout semaglutide
  • Newer name with a thinner public track record

Also worth a look

Patients who want a single LegitScript-verified operator carrying far more than a GLP-1 — oral and microdosed options, peptides and bioidentical HRT — and will accept compounded-only meds and a long annual lock-in in exchange for the lowest published prices.

Visit Telos Rx Read the full Telos Rx review →

Our pick — visit

Value shoppers who refuse to trade price for legitimacy — the strongest all-around bargain on the board.

Visit Ondra Health Read the full Ondra Health review →

Keep comparing

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.